Related Experiment Video
Updated: May 8, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Social egg freezing: which problems?].
J Belaisch-Allart1, M Brzakowski, A Chouraqui
1Service de gynécologie obstétrique et médecine de la reproduction, centre hospitalier des 4-Villes, site de Sèvres, 141, Grande-Rue, 92318 Sèvres cedex, France. j.belaischallart@ch4v.fr
Gynecologie, Obstetrique & Fertilite
|August 27, 2013
Summary
Women are delaying childbirth, impacting fertility. Oocyte vitrification (egg freezing) offers a solution, with its effectiveness proven and legal in France for specific cases, sparking wider social discussions.
Area of Science:
- Reproductive medicine
- Gynecology
- Genetics
Context:
- Increasing trend of delayed childbearing among women.
- Limitations of assisted reproductive technologies in overcoming age-related fertility decline.
- Legal and ethical considerations surrounding fertility preservation.
Purpose:
- To evaluate the effectiveness of oocyte vitrification (egg freezing) as a fertility preservation method.
- To discuss the implications of oocyte vitrification in the context of French Bioethics law.
- To explore the societal debates surrounding social egg freezing for non-medical reasons.
Summary:
- Assisted reproduction techniques, excluding egg donation, are insufficient to counteract age-related fertility loss.
- Oocyte vitrification has demonstrated effectiveness and is legally permitted in France under specific conditions, such as for oocyte donors without children.
- Social egg freezing for elective, non-medical reasons is legal in some nations, prompting ongoing ethical and social discourse.
Impact:
- Oocyte vitrification provides a viable option for women wishing to preserve fertility due to delayed childbearing.
- The legal framework in France, including provisions for oocyte donors, highlights the growing acceptance of fertility preservation technologies.
- Societal discussions on social egg freezing underscore the evolving perspectives on reproductive choices and family planning.
Related Concept Videos
01:57Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...